These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19371757)

  • 1. Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses.
    Zhang Q; Pi J; Woods CG; Andersen ME
    Toxicol Appl Pharmacol; 2009 Jun; 237(3):345-56. PubMed ID: 19371757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
    Xu C; Li CY; Kong AN
    Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochromes P450 in the bioactivation of chemicals.
    Ioannides C; Lewis DF
    Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
    Braeuning A; Sanna R; Huelsken J; Schwarz M
    Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Xenobiotic Detoxification Pathway through Transcriptional Regulation in Filamentous Fungi.
    Sang H; Hulvey JP; Green R; Xu H; Im J; Chang T; Jung G
    mBio; 2018 Jul; 9(4):. PubMed ID: 30018104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection.
    Sonoda J; Rosenfeld JM; Xu L; Evans RM; Xie W
    Curr Drug Metab; 2003 Feb; 4(1):59-72. PubMed ID: 12570746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting effects of acute and chronic dietary exposure to 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) on xenobiotic metabolising enzymes in the male Fischer 344 rat: implications for chemoprevention studies.
    McPherson RA; Tingle MD; Ferguson LR
    Eur J Nutr; 2001 Feb; 40(1):39-47. PubMed ID: 11315504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE).
    Kong AN; Owuor E; Yu R; Hebbar V; Chen C; Hu R; Mandlekar S
    Drug Metab Rev; 2001; 33(3-4):255-71. PubMed ID: 11768769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design.
    Rekka EA; Kourounakis PN; Pantelidou M
    Curr Top Med Chem; 2019; 19(4):276-291. PubMed ID: 30706817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
    Rendic SP; Guengerich FP
    Arch Toxicol; 2021 Feb; 95(2):395-472. PubMed ID: 33459808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Biotransformation of Drugs and other Xenobiotics.
    Orhan H; Karakuş F; Ergüç A
    Curr Drug Metab; 2021; 22(8):657-669. PubMed ID: 34182906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-metabolizing enzymes: mechanisms and functions.
    Sheweita SA
    Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 and xenobiotic receptor humanized mice.
    Gonzalez FJ; Yu AM
    Annu Rev Pharmacol Toxicol; 2006; 46():41-64. PubMed ID: 16402898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor.
    Köhle C; Bock KW
    Biochem Pharmacol; 2009 Feb; 77(4):689-99. PubMed ID: 18606396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions.
    Kalgutkar AS; Obach RS; Maurer TS
    Curr Drug Metab; 2007 Jun; 8(5):407-47. PubMed ID: 17584015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.
    Moon YJ; Wang X; Morris ME
    Toxicol In Vitro; 2006 Mar; 20(2):187-210. PubMed ID: 16289744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems.
    Nakata K; Tanaka Y; Nakano T; Adachi T; Tanaka H; Kaminuma T; Ishikawa T
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):437-57. PubMed ID: 17220560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 Induction and Xeno-Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor α at the Crossroads of Toxicokinetics and Toxicodynamics.
    Hakkola J; Bernasconi C; Coecke S; Richert L; Andersson TB; Pelkonen O
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():42-50. PubMed ID: 29527807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptor AHR-mediated xenobiotic detoxification pathway involves in atrazine-induced nephrotoxicity in quail (Coturnix C. coturnix).
    Zhang C; Li H; Qin L; Ge J; Qi Z; Talukder M; Li YH; Li JL
    Environ Pollut; 2019 Oct; 253():889-898. PubMed ID: 31349198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.